We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

126 hedge funds and large institutions have $391M invested in ANI Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 33

32% more call options, than puts

Call options by funds: $905K | Put options by funds: $688K

18% more capital invested

Capital invested by funds: $330M → $391M (+$61M)

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

0% more funds holding

Funds holding: 126 → 126 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.18% less ownership

Funds ownership: 58.92% → 58.74% (-0.18%)

Holders
126
Holders Change
–
Holders Change %
0%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
46
Reduced
33
Closed
18
Calls
$905K
Puts
$688K
Net Calls
+$217K
Net Calls Change
+$1.21M

Top Buyers

1
RCMNY
Rubric Capital Management (New York)
New York
+$3.35M
2
BlackRock
BlackRock
New York
+$2.2M
3
ACM
AIGH Capital Management
Maryland
+$1.64M
4
SSA
Schonfeld Strategic Advisors
New York
+$1.5M
5
RCAMU
Rothschild & Co Asset Management US
Connecticut
+$1.31M

Top Sellers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.47M
2
TCM
Tang Capital Management
California
-$3.21M
3
SCM
Sio Capital Management
New York
-$1.29M
4
LSV Asset Management
LSV Asset Management
Illinois
-$1.14M
5
JCIA
Jackson Creek Investment Advisors
Colorado
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$594K +$1.24K +33 +0.2%
Commonwealth Equity Services
52
Commonwealth Equity Services
Massachusetts
$548K +$18.8K +500 +4%
COPPSERS
53
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$526K +$78.2K +2,083 +19%
Canada Life
54
Canada Life
Manitoba, Canada
$507K +$19.2K +510 +4%
Thrivent Financial for Lutherans
55
Thrivent Financial for Lutherans
Minnesota
$504K +$2.25K +60 +0.5%
Prudential Financial
56
Prudential Financial
New Jersey
$495K -$5.63K -150 -1%
State of Wisconsin Investment Board
57
State of Wisconsin Investment Board
Wisconsin
$488K -$29.3K -779 -6%
SEI Investments
58
SEI Investments
Pennsylvania
$477K +$445K +11,858 New
Ensign Peak Advisors
59
Ensign Peak Advisors
Utah
$464K +$162K +4,300 +59%
JAM
60
Jupiter Asset Management
United Kingdom
$413K – – –
DekaBank Deutsche Girozentrale
61
DekaBank Deutsche Girozentrale
Germany
$408K +$376K +10,000 New
PGFC
62
Peapack-Gladstone Financial Corp
New Jersey
$402K – – –
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$380K -$1.39K -37 -0.4%
GCM
64
Graham Capital Management
Connecticut
$352K +$328K +8,744 New
PCM
65
Perkins Capital Management
Minnesota
$343K – – –
SOADOR
66
State of Alaska Department of Revenue
Alaska
$342K +$5.56K +148 +2%
BCM
67
BTC Capital Management
Iowa
$331K +$309K +8,217 New
TPSF
68
Texas Permanent School Fund
Texas
$330K -$17.6K -469 -5%
Citigroup
69
Citigroup
New York
$321K +$38.9K +1,036 +15%
YCM
70
Yousif Capital Management
Michigan
$315K -$77K -2,050 -21%
TC
71
Tejara Capital
United Kingdom
$306K +$285K +7,600 New
MFIM
72
Mesirow Financial Investment Management
Illinois
$277K – – –
AIG
73
American International Group
New York
$277K +$939 +25 +0.4%
UBS Group
74
UBS Group
Switzerland
$274K +$254K +6,773 +15,393%
Two Sigma Advisers
75
Two Sigma Advisers
New York
$270K -$451K -12,000 -64%
1 2
3
4 5

ANIP Hedge Fund Activity: Q4 2022 in Review

126 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2022, worth a combined $391M — up 18% from $330M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ANIP positions and 18 closed out — a net gain of 1 holder — while 46 added to existing stakes and 33 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $3.35M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $4.47M sold.

  • 126 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $391M of ANI Pharmaceuticals stock for Q4 2022, up 18% quarter-over-quarter.
  • 19 funds opened new ANI Pharmaceuticals positions in Q4 2022 and 18 closed out, a net change of +1 holder.
  • The largest ANI Pharmaceuticals buyer in Q4 2022 was Rubric Capital Management (New York), an estimated $3.35M added.
  • The largest ANI Pharmaceuticals seller in Q4 2022 was Balyasny Asset Management, an estimated $4.47M sold.

Based on aggregated 13F filings for Q4 2022.